US Patent 8404684 Inhibitors of phosphatidylinositol 3-kinase
Patent 8404684 was granted and assigned to Novartis on March, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+37 characters)
Article
Patent abstract
Compounds of formula I
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08404684 Inhibitors of phosphatidylinositol 3-kinase US Patent 8404684 Inhibitors of phosphatidylinositol 3-kinase
Infobox
Patent Number
0840468400
Patent Number
840468400
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084046840
Date of Patent
March 26, 2013
0Patent Application Number
130051320
Date Filed
January 12, 2011
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084046840
Date of Patent
March 26, 2013
0Patent Application Number
130051320
Date Filed
January 12, 2011
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08404684 Inhibitors of phosphatidylinositol 3-kinase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08404684
Date of patent
March 26, 2013
Patent application number
13005132
Date Filed
January 12, 2011
Patent primary examiner
Find more entities like US Patent 8404684 Inhibitors of phosphatidylinositol 3-kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
